Striving towards true equity in global health: a checklist for bilateral research partnerships
DZ Hodson, YM Etoundi, S Parikh… - PLOS Global Public …, 2023 - journals.plos.org
Interest in “global health” among schools of medicine, public health, and other health
disciplines in high-income countries (HIC) continues to rise. Persistent power imbalances …
disciplines in high-income countries (HIC) continues to rise. Persistent power imbalances …
Evidence of Plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in western Cambodia: dihydroartemisinin-piperaquine open-label …
R Leang, WRJ Taylor, DM Bouth, L Song… - Antimicrobial agents …, 2015 - Am Soc Microbiol
Western Cambodia is recognized as the epicenter of Plasmodium falciparum multidrug
resistance. Recent reports of the efficacy of dihydroartemisinin (DHA)-piperaquine (PP), the …
resistance. Recent reports of the efficacy of dihydroartemisinin (DHA)-piperaquine (PP), the …
Antimalarial treatment in infants
LC Kalkman, T Hanscheid, S Krishna… - Expert opinion on …, 2022 - Taylor & Francis
Introduction Malaria in infants is common in high-transmission settings, especially in infants>
6 months. Infants undergo physiological changes impacting pharmacokinetics and …
6 months. Infants undergo physiological changes impacting pharmacokinetics and …
Pharmacokinetics‐pharmacodynamics of high‐dose ivermectin with dihydroartemisinin‐piperaquine on mosquitocidal activity and QT‐prolongation (IVERMAL)
High‐dose ivermectin, co‐administered for 3 days with dihydroartemisinin‐piperaquine
(DP), killed mosquitoes feeding on individuals for at least 28 days posttreatment in a recent …
(DP), killed mosquitoes feeding on individuals for at least 28 days posttreatment in a recent …
Dihydroartemisinin–piperaquine treatment failure in uncomplicated Plasmodium falciparum malaria case imported from Ethiopia
G Russo, M L'Episcopia, M Menegon, SS Souza… - Infection, 2018 - Springer
Abstract Dihydroartemisinin–piperaquine (DHA–PPQ) is the artemisinin combination
therapy that was recently introduced for the treatment of Plasmodium falciparum …
therapy that was recently introduced for the treatment of Plasmodium falciparum …
Treatment outcomes in a safety observational study of dihydroartemisinin/piperaquine (Eurartesim®) in the treatment of uncomplicated malaria at public health …
A Adjei, S Narh-Bana, A Amu, V Kukula, RA Nagai… - Malaria journal, 2016 - Springer
Abstract Background Dihydroartemisinin-piperaquine (DHA-PQ) is one of five WHO
recommended artemisinin combination therapy (ACT) for the treatment of uncomplicated …
recommended artemisinin combination therapy (ACT) for the treatment of uncomplicated …
Impact of Drug Exposure on Resistance Selection Following Artemether‐Lumefantrine Treatment for Malaria in Children With and Without HIV in Uganda
Artemisinin‐based combination therapies (ACTs) are the primary treatment for malaria. It is
essential to characterize the pharmacokinetics (PKs) and pharmacodynamics (PDs) of ACTs …
essential to characterize the pharmacokinetics (PKs) and pharmacodynamics (PDs) of ACTs …
Ex vivo drug susceptibility and resistance mediating genetic polymorphisms of Plasmodium falciparum in Bobo-Dioulasso, Burkina Faso
AF Somé, MD Conrad, Z Kabré, A Fofana… - Antimicrobial Agents …, 2024 - Am Soc Microbiol
Malaria remains a leading cause of morbidity and mortality in Burkina Faso, which utilizes
artemether–lumefantrine as the principal therapy to treat uncomplicated malaria and …
artemether–lumefantrine as the principal therapy to treat uncomplicated malaria and …
Comparison of lumefantrine, mefloquine, and piperaquine concentrations between capillary plasma and venous plasma samples in pregnant women with …
M Saito, P Wilaisrisak, M Pimanpanarak… - Antimicrobial Agents …, 2024 - Am Soc Microbiol
Capillary samples offer practical benefits compared with venous samples for the
measurement of drug concentrations, but the relationship between the two measures varies …
measurement of drug concentrations, but the relationship between the two measures varies …
Failure of dihydroartemisinin-piperaquine treatment of uncomplicated Plasmodium falciparum malaria in a traveller coming from Ethiopia
F Gobbi, D Buonfrate, M Menegon, G Lunardi… - Malaria Journal, 2016 - Springer
Background Artemisinin combination therapy (ACT) is used worldwide as the first-line
treatment against uncomplicated Plasmodium falciparum malaria. Despite the success of …
treatment against uncomplicated Plasmodium falciparum malaria. Despite the success of …